Accrued Expenses and Other Liabilities

12 Months Ended

Dec. 31, 2024

Accrued Expenses and Other Liabilities

Accrued Expenses and Other Liabilities

9.        Accrued Expenses and Other Liabilities

Accrued expenses and other liabilities consist of the following at:

	December 31,		December 31,
	2024		2023
Accrued marketing expenses	$	999,996	$	1,013,497
Accrued preclinical and clinical trial expenses		364,460		405,792
Compensation and related benefits		298,090		332,641
Other expenses		268,161		313,254
Advance payments received from customers for manufacturing materials		169,758		—
Accrued manufacturing expenses		59,793		97,877
Accrued franchise tax		—		38,800
	$	2,160,258	$	2,201,861